Examining Analgesic Synergy and Efficacy in Trauma Care (NCT07435077)
Examining Analgesic Synergy and Efficacy in Trauma Care-A Randomized, Control Study of Buprenorphine Versus Oxycodone in Multimodal Pain Control Regimens
๐ฉบ Plain-English Summary (8th-Grade Level)
Traumatic injury is responsible for over 25 million (16%) Emergency Department visits and over 225,000 deaths each year per 2021 Center for Disease Control data. This is the 3rd leading cause of death in the US. Often, acute care for the injured patient requires administration of pain medication for the purposes of acute pain control from injury. The mainstay of treatment for pain control has historically involved opioid pain medication.
Who can join: Review the eligibility criteria below.
Location: Wake Forest University Health Sciences โ Winston-Salem, North Carolina
Age range: 18 Years to 80 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Wake Forest University Health Sciences โ Winston-Salem, North Carolina
๐ Contact the Study Coordinator
Phone: (336) 716-1659
Email: Dann.Hershel@wfusm.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Opioid Use Disorder
- Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder โ Atlantic City, New Jersey
- The Emergency Department Longitudinal Integrated Care โ Seattle, Washington
- Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT โ La Jolla, California
- Extended-release Buprenorphine as a Novel Low-dose Induction Strategy โ Boston, Massachusetts
- Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial โ Ann Arbor, Michigan
- Telemedicine XR-B for Individuals in Jail โ Cumberland, Maryland
Explore by condition: All Opioid Use Disorder clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.